Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries

John D. Edwards, Patrick E. McGregor, Peter S. Dovgan, Devendra K. Agrawal

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Endothelin-1 (ET-1) has been proposed as one of the possible mediators of the vasoconstriction seen following ischemia and reperfusion. We investigated the effect of ischemia and reperfusion on the contractile response of canine renal and iliac arteries to the dihydropyridine-type calcium channel agonist (±)Bay K 8644, following subthreshold doses of ET-1. No significant difference in the maximum tension was observed betweeen the ischemic and nonischemic arteries in response to Bay K 8644 in the absence of ET-1. The addition of subthreshold dose of ET-1 (10-10M) resulted in a significant increase in sensitivity to Bay K 8644 in both the ischemic-reperfused and non-ischemic-reperfused arteries, with a 38 fold increase in iliac arteries and about 8 fold increase in the renal arteries. However, the ET-1 potentiated response was enhanced in the ischemic-reperfused in comparison to the non-ischemic-reperfused vessels in the iliac artery. These data suggest that the potentiating mechanism of ET-1 is not only intact, but enhanced in ischemicreperfused vessels. Since the enhanced release of ET-1 in vivo is preceded by ischemia and reperfusion, the vasospastic phenomenon observed following these events could well be mediated by ET-1.

Original languageEnglish
Pages (from-to)225-234
Number of pages10
JournalLife Sciences
Volume57
Issue number3
DOIs
StatePublished - Jun 9 1995

Fingerprint

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Endothelin-1
Arteries
Iliac Artery
Reperfusion
Ischemia
Renal Artery
Calcium Channel Agonists
Vasoconstriction
Canidae

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology

Cite this

Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries. / Edwards, John D.; McGregor, Patrick E.; Dovgan, Peter S.; Agrawal, Devendra K.

In: Life Sciences, Vol. 57, No. 3, 09.06.1995, p. 225-234.

Research output: Contribution to journalArticle

Edwards, John D. ; McGregor, Patrick E. ; Dovgan, Peter S. ; Agrawal, Devendra K. / Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries. In: Life Sciences. 1995 ; Vol. 57, No. 3. pp. 225-234.
@article{57eef7f6830444428a02cbf8e926c83a,
title = "Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries",
abstract = "Endothelin-1 (ET-1) has been proposed as one of the possible mediators of the vasoconstriction seen following ischemia and reperfusion. We investigated the effect of ischemia and reperfusion on the contractile response of canine renal and iliac arteries to the dihydropyridine-type calcium channel agonist (±)Bay K 8644, following subthreshold doses of ET-1. No significant difference in the maximum tension was observed betweeen the ischemic and nonischemic arteries in response to Bay K 8644 in the absence of ET-1. The addition of subthreshold dose of ET-1 (10-10M) resulted in a significant increase in sensitivity to Bay K 8644 in both the ischemic-reperfused and non-ischemic-reperfused arteries, with a 38 fold increase in iliac arteries and about 8 fold increase in the renal arteries. However, the ET-1 potentiated response was enhanced in the ischemic-reperfused in comparison to the non-ischemic-reperfused vessels in the iliac artery. These data suggest that the potentiating mechanism of ET-1 is not only intact, but enhanced in ischemicreperfused vessels. Since the enhanced release of ET-1 in vivo is preceded by ischemia and reperfusion, the vasospastic phenomenon observed following these events could well be mediated by ET-1.",
author = "Edwards, {John D.} and McGregor, {Patrick E.} and Dovgan, {Peter S.} and Agrawal, {Devendra K.}",
year = "1995",
month = "6",
day = "9",
doi = "10.1016/0024-3205(95)00267-A",
language = "English",
volume = "57",
pages = "225--234",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries

AU - Edwards, John D.

AU - McGregor, Patrick E.

AU - Dovgan, Peter S.

AU - Agrawal, Devendra K.

PY - 1995/6/9

Y1 - 1995/6/9

N2 - Endothelin-1 (ET-1) has been proposed as one of the possible mediators of the vasoconstriction seen following ischemia and reperfusion. We investigated the effect of ischemia and reperfusion on the contractile response of canine renal and iliac arteries to the dihydropyridine-type calcium channel agonist (±)Bay K 8644, following subthreshold doses of ET-1. No significant difference in the maximum tension was observed betweeen the ischemic and nonischemic arteries in response to Bay K 8644 in the absence of ET-1. The addition of subthreshold dose of ET-1 (10-10M) resulted in a significant increase in sensitivity to Bay K 8644 in both the ischemic-reperfused and non-ischemic-reperfused arteries, with a 38 fold increase in iliac arteries and about 8 fold increase in the renal arteries. However, the ET-1 potentiated response was enhanced in the ischemic-reperfused in comparison to the non-ischemic-reperfused vessels in the iliac artery. These data suggest that the potentiating mechanism of ET-1 is not only intact, but enhanced in ischemicreperfused vessels. Since the enhanced release of ET-1 in vivo is preceded by ischemia and reperfusion, the vasospastic phenomenon observed following these events could well be mediated by ET-1.

AB - Endothelin-1 (ET-1) has been proposed as one of the possible mediators of the vasoconstriction seen following ischemia and reperfusion. We investigated the effect of ischemia and reperfusion on the contractile response of canine renal and iliac arteries to the dihydropyridine-type calcium channel agonist (±)Bay K 8644, following subthreshold doses of ET-1. No significant difference in the maximum tension was observed betweeen the ischemic and nonischemic arteries in response to Bay K 8644 in the absence of ET-1. The addition of subthreshold dose of ET-1 (10-10M) resulted in a significant increase in sensitivity to Bay K 8644 in both the ischemic-reperfused and non-ischemic-reperfused arteries, with a 38 fold increase in iliac arteries and about 8 fold increase in the renal arteries. However, the ET-1 potentiated response was enhanced in the ischemic-reperfused in comparison to the non-ischemic-reperfused vessels in the iliac artery. These data suggest that the potentiating mechanism of ET-1 is not only intact, but enhanced in ischemicreperfused vessels. Since the enhanced release of ET-1 in vivo is preceded by ischemia and reperfusion, the vasospastic phenomenon observed following these events could well be mediated by ET-1.

UR - http://www.scopus.com/inward/record.url?scp=0028999935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028999935&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(95)00267-A

DO - 10.1016/0024-3205(95)00267-A

M3 - Article

VL - 57

SP - 225

EP - 234

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 3

ER -